At the latest stages (>D26) of GBM progression, CD11c-EYFP+ cells were still present, although their density decreased by half inside the tumor (D19, 224 ± 26 cells/mm2; D29, 100 ± 17 cells/mm2; Fig. 2b,d). The gene discussed is ITGAX; the disease is glioblastoma.